NasdaqGM - Delayed Quote USD

Eton Pharmaceuticals, Inc. (ETON)

18.89
-0.03
(-0.16%)
At close: May 30 at 4:00:02 PM EDT
18.89
0.00
(0.00%)
After hours: May 30 at 6:16:12 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
48,327
39,011
31,642
21,251
21,832
Cost of Revenue
20,062
15,600
10,581
6,933
2,827
Gross Profit
28,265
23,411
21,061
14,318
19,005
Operating Expense
30,532
26,008
22,253
22,578
20,500
Operating Income
-2,267
-2,597
-1,192
-8,260
-1,495
Net Non Operating Interest Income Expense
-2,228
-1,211
503
-761
-1,006
Other Income Expense
--
--
--
--
546
Pretax Income
-4,495
-3,808
-689
-9,021
-1,955
Tax Provision
89
15
247
0
0
Net Income Common Stockholders
-4,584
-3,823
-936
-9,021
-1,955
Diluted NI Available to Com Stockholders
-4,584
-3,823
-936
-9,021
-1,955
Basic EPS
-0.18
-0.15
-0.04
-0.36
-0.08
Diluted EPS
-0.18
-0.15
-0.04
-0.36
-0.08
Basic Average Shares
26,175.75
25,895
25,645
25,146
25,207
Diluted Average Shares
26,175.75
25,895
25,645
25,146
25,207
Total Operating Income as Reported
-2,267
-2,597
-1,192
-8,260
-1,495
Total Expenses
50,594
41,608
32,834
29,511
23,327
Net Income from Continuing & Discontinued Operation
-4,584
-3,823
-936
-9,021
-1,955
Normalized Income
-4,584
-3,823
-936
-9,021
-2,501
Net Interest Income
-2,228
-1,211
503
-761
-1,006
EBIT
-2,267
-2,597
-1,192
-8,260
-1,495
EBITDA
-342
-1,451
-291
-6,486
-1,033
Reconciled Cost of Revenue
20,062
15,600
10,581
6,933
2,827
Reconciled Depreciation
1,925
1,146
901
1,774
462
Net Income from Continuing Operation Net Minority Interest
-4,584
-3,823
-936
-9,021
-1,955
Total Unusual Items Excluding Goodwill
--
--
0
0
546
Total Unusual Items
--
--
0
0
546
Normalized EBITDA
-342
-1,451
-291
-6,486
-1,579
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2021 - 11/13/2018

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

HROW Harrow, Inc.
28.11
+3.35%
 
AQST Aquestive Therapeutics, Inc.
2.7100
-2.87%
 
BCRX BioCryst Pharmaceuticals, Inc.
10.75
-1.19%
 
DERM Journey Medical Corporation
8.06
-0.12%
 
ALKS Alkermes plc
30.61
+1.19%
 
UTHR United Therapeutics Corporation
318.85
-0.47%
 
AKBA Akebia Therapeutics, Inc.
3.0300
+0.66%
 
DVAX Dynavax Technologies Corporation
9.79
+0.31%
 
SCYX SCYNEXIS, Inc.
0.8751
-2.15%
 
BGM BGM Group Ltd.
13.39
-4.29%